SOURCE: TSRL, Inc.

November 11, 2010 14:42 ET

TSRL, Inc. Awarded Four Therapeutic Discovery Tax Credit Grants

ANN ARBOR, MI--(Marketwire - November 11, 2010) - Therapeutic Systems Research Laboratories, (TSRL), Inc. announced today receipt of four grants through the Therapeutic Discovery Tax Credit Program totaling $573,095. The grants were awarded against investments TSRL made in the development of oral prodrugs for influenza, human cytomegalovirus (CMV) and smallpox infections, development of novel local therapeutics for the treatment of IBD and an absorption enhancing technology.

TSRL will use these funds to advance their lead influenza therapeutics candidate to IND.

About Therapeutic Systems Research Laboratories

Therapeutic Systems Research Laboratories (TSRL), Inc. is a privately held oral drug delivery specialty firm. TSRL is focused on R&D efforts to enhance the oral absorption of investigational and marketed compounds currently not suitable for this most convenient route of drug administration. TSRL provides preclinical development research services in early formulation development, PK/ADME and BCS biowaiver data packages. More detailed information about TSRL is available at the company website www.tsrlinc.com.

Contact Information

  • For additional information contact
    Dr. Elke Lipka
    Vice President of Business Development
    734 663-4233 x236
    Email Contact